Shelley Jambresic

Group Lead Science & Evaluation at Geistlich Pharma AG

Advisor

Shelley Jambresic is a Group Lead Science & Evaluation at Geistlich Pharma, responsible for clinical evaluation and clinical data interpretation of class III medical devices of animal origin. She is experienced in planning and conducting pre- and post-market clinical trials with medical devices and had the lead for implementation of MDR requirements in clinical processes at Geistlich Pharma. By training, Shelley Jambresic is a microbiologist and science communicator with extensive experience in medical and science writing.